UBS Group
INCR

UBS Group’s Intercure INCR Stock Holding History

UBS Group’s Portfolio INCR Stock Details INCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47K Buy
+267
New +$1.19K ﹤0.01% 9545
2025
Q4 		– Sell
-118
Closed -$969 – 10834
2025
Q3 		$969 Sell
118
-1,530
-93% -$11.9K ﹤0.01% 9476
2025
Q2 		$12.1K Buy
+1,648
New +$12.2K ﹤0.01% 8751
2024
Q4 		– Sell
-9
Closed -$88 – 10152
2024
Q3 		$88 Buy
+9
New +$94 ﹤0.01% 9173
2024
Q2 		– Sell
-902
Closed -$12.2K – 9776
2024
Q1 		$12.2K Sell
902
-1,078
-54% -$9.18K ﹤0.01% 7145
2023
Q4 		$12.8K Buy
1,980
+1,839
+1,304% +$11.2K ﹤0.01% 7338
2023
Q3 		$1.11K Buy
+141
New +$1.13K ﹤0.01% 8099
2023
Q2 		– Sell
-340
Closed -$3.46K – 9238
2023
Q1 		$3.46K Sell
340
-53
-13% -$797 ﹤0.01% 8318
2022
Q4 		$6.49K Sell
393
-874
-69% -$20.2K ﹤0.01% 9027
2022
Q3 		$29K Buy
1,267
+874
+222% +$23.8K ﹤0.01% 6919
2022
Q2 		$11K Sell
393
-1,681
-81% -$53.1K ﹤0.01% 7812
2022
Q1 		$74K Sell
2,074
-15,146
-88% -$501K ﹤0.01% 6121
2021
Q4 		$558K Sell
17,220
-5,624
-25% -$202K ﹤0.01% 4895
2021
Q3 		$792K Buy
+22,844
New +$820K ﹤0.01% 4380

Other funds holding INCR

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RWM
Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
QC
Quent Capital New York $1.63B AUM 27.42% 1-Year Est. Return

UBS Group's INCR Position: Q2 2026 in Review

UBS Group opened a new position in Intercure (INCR) in Q2 2026: 267 shares worth $1.47K. The stake represents ﹤0.01% of the portfolio and ranks #9545 among its holdings. This is a return to the name: UBS Group previously reported a position in INCR as recently as Q3 2025.

UBS Group first reported a position in INCR in Q3 2021 and has held it in 14 quarters since. The position peaked at $792K in Q3 2021. 16 funds tracked by Wall St. Rank hold INCR as of Q2 2026.

  • UBS Group held 267 shares of Intercure worth $1.47K as of Q2 2026.
  • Intercure was a new UBS Group position in Q2 2026.
  • Intercure made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9545 holding.
  • UBS Group first reported a position in Intercure in Q3 2021 and has held it in 14 quarters since.
  • UBS Group's Intercure position peaked at $792K in Q3 2021.
  • 16 funds tracked by Wall St. Rank held Intercure as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.